CORONAVIRUS NEWS
Interim trial results published for Oxford vaccine
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases
Cancer risk factors for mortality following COVID
Cancer and cancer treatment are both independent risk factors for mortality following COVID-19 infection, according to UCLH led research which highlights the ongoing need to protect cancer patients during the pandemic.
COVID infections fall by over 50% in the North West and North East
Interim results from the seventh report of one of the country’s largest studies into COVID-19 infections in England have been published by Imperial College London and Ipsos MORI.
COVID-19: study highlights importance of early use of CPAP
The lives of patients hospitalised with COVID-19 are being saved by doctors who are using an existing medical treatment at an earlier stage.
Sheffield Trust chosen to lead major Covid-19 vaccine trial
Sheffield Teaching Hospitals NHS Foundation Trust is one of 17 sites across the country, and the only one in the Yorkshire and Humber, to have been selected to trial the latest Covid-19 candidate vaccine.
UCL steps up testing of immune response in care homes
The Vivaldi 2 study will more than triple in size to provide a detailed picture of coronavirus infection in care homes in England.
Beckman Coulter launches its SARS-CoV-2 IgM antibody test
Beckman Coulter has announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark.
UK ramps up vaccine manufacture capabilities
The Vaccines Manufacturing and Innovation Centre (VMIC) has announced rapid expansion of recruitment, in order to meet anticipated demand in 2021.
NHS response to the Prime Minister’s lockdown announcement
Responding to the Prime Minister’s statement on coronavirus, NHS Medical Director, Professor Stephen Powis, said: “Daily hospital COVID admissions are now higher than on 23 March when the Prime Minister announced the first national lockdown.
Imperial vaccine lead says COVID is here for years to come
Imperial’s COVID-19 vaccine lead, Professor Robin Shattock, has told MPs that there is uncertainty around the immunity that a vaccine will offer; boosting strategies may be required and we are likely to be living with the virus for years to come.
Research on blood pressure allays COVID fears
Fears that people with high blood pressure are more at risk from severe COVID-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.
Antiviral drugs trialled in the early stages of COVID-19
Two antiviral drugs are being given to COVID-19 positive adults to establish if they stop the virus replicating, as part of a trial led by UCL scientists.
UK guideline on management of the long-term effects of COVID-19
NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) have given more details about the forthcoming guideline on post-COVID syndrome which is due to be published by the end of the year.
Study shows myocarditis linked to COVID-19 not as common as believed
A new study suggests myocarditis caused by COVID-19 may be a relatively rare occurrence.
COVID transmission infection risk in psoriatic patients
Biologics increase COVID-19 infection risk but may protect psoriatic patients from ICU hospitalisation and death.
Sewage signals early warning of coronavirus outbreaks
A government-led project is successfully detecting traces of coronavirus in sewage, providing an early warning for local outbreaks across the country and sharing data with NHS Test and Trace.
Hundreds of Birmingham A&E patients may be turned away
Hundreds of patients who turn up to A&E departments in Birmingham may be turned away in a bid to protect key services, health bosses have said.
Surgeons call for ring-fenced beds
Leading surgeons are calling for hospital beds to be ring-fenced for planned operations, to avoid a ‘tsunami of cancellations’ during the second wave of COVID-19.
NICE and SIGN announce latest guideline will address Long COVID
NICE and the Scottish Intercollegiate Guidelines Network (SIGN) have announced they will work with the Royal College of General Practitioners (RCGP) to develop a guideline on persistent effects of COVID-19 (Long Covid) on patients.
NHS to offer ‘long COVID’ sufferers help at specialist centres
People suffering ‘long COVID’ symptoms will be offered specialist help at clinics across England, the head of the NHS has announced.
Featured Supplier
Our prime objective is to provide product solutions and services that fully satisfy our customers’ requirements and expectations.
Starkstrom is a British company, founded in 1971, which initially specialised in designing and building control panel equipment. The company has its own UK manufacturing facility and supplies operating room...
Upcoming Events
IP2022 IS COMING TO BOURNEMOUTH IN OCTOBER 2022
Bournemouth
17-19 October 2022
UKHCA Conference: Listen Up
Pendulum Hotel and Manchester Conference Centre, Manchester
3rd November 2022
MEDICA 2022
Dusseldorf Germany
14th November - 17th November
Future Surgery 2022
ExCel, London
15th - 16th November 2022
IDSc Annual Conference
The Eastside Rooms, Birmingham
29th - 30th November 2022
Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.
Download the FREE Clinical Services Journal app from your device's App store
